Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
40 hedge funds and large institutions have $124M invested in Global Cord Blood Corporation in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 6 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3% more funds holding
Funds holding: 39 → 40 (+1)
18% less capital invested
Capital invested by funds: $151M → $124M (-$27.2M)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.5M |
| 2 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$1.36M |
| 3 |
Man Group
London,
United Kingdom
|
+$1.32M |
| 4 |
Renaissance Technologies
New York
|
+$194K |
| 5 |
SG Americas Securities
New York
|
+$174K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.35M |
| 2 |
JCM
Jayhawk Capital Management
Shawnee,
Kansas
|
-$1.11M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$504K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$298K |
| 5 |
Two Sigma Investments
New York
|
-$289K |
CO Hedge Fund Activity: Q2 2019 in Review
40 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2019, worth a combined $124M — down 18% from $151M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CO positions and 6 closed out — a net gain of 1 holder — while 8 added to existing stakes and 11 trimmed.
The largest buyer was Credit Suisse, opening a new position worth an estimated $1.5M. The largest seller was UBS Group, cutting an estimated $2.35M.
- 40 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2019, up from 39 in Q1 2019.
- Funds reported $124M of Global Cord Blood Corporation stock for Q2 2019, down 18% quarter-over-quarter.
- 7 funds opened new Global Cord Blood Corporation positions in Q2 2019 and 6 closed out, a net change of +1 holder.
- The largest Global Cord Blood Corporation buyer in Q2 2019 was Credit Suisse, an estimated $1.5M added.
- The largest Global Cord Blood Corporation seller in Q2 2019 was UBS Group, an estimated $2.35M sold.
Based on aggregated 13F filings for Q2 2019.